13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...4, 5, 6, 7, 8, ...17, 18, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-01-18
4:29 pm
Purchase
2023-12-3113GAllakos Inc.
ALLK
BIOTECHNOLOGY VALUE FUND L P8,552,417
9.800%
3,545,496increase
(+70.81%)
Filing
History
2024-01-18
4:18 pm
Purchase
2024-01-0813GImmunic, Inc.
IMUX
BIOTECHNOLOGY VALUE FUND L P8,902,972
9.900%
8,902,972increase
(New Position)
Filing
History
2024-01-16
5:22 pm
Purchase
2024-01-1113DXOMA Corporation
XOMA
BIOTECHNOLOGY VALUE FUND L P3,633,743
31.600%
103,200increase
(+2.92%)
Filing
History
2024-01-09
4:45 pm
Purchase
2024-01-0513DKymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P5,831,171
9.990%
1,138,567increase
(+24.26%)
Filing
History
2023-12-20
4:38 pm
Sale
2023-12-1813DPOINT Biopharma Global Inc.
PNT
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-17,437,375decrease
(Position Closed)
Filing
History
2023-12-20
4:36 pm
Sale
2023-12-1813GStructure Therapeutics Inc.
GPCR
BIOTECHNOLOGY VALUE FUND L P2,438,964
1.800%
-10,221,554decrease
(-80.74%)
Filing
History
2023-12-19
4:53 pm
Purchase
2023-12-1513GAC Immune S.A.
ACIU
BIOTECHNOLOGY VALUE FUND L P14,571,236
14.800%
7,142,857increase
(+96.16%)
Filing
History
2023-12-18
4:35 pm
Unchanged
2023-12-1313DRain Enhancement Technologies Holdco Inc
RAIN
BIOTECHNOLOGY VALUE FUND L P3,526,729
12.800%
0
(Unchanged)
Filing
History
2023-12-04
4:33 pm
Purchase
2023-11-2213GSAB Biotherapeutics, Inc.
SABS
BIOTECHNOLOGY VALUE FUND L P917,828
9.990%
917,828increase
(New Position)
Filing
History
2023-11-20
5:07 pm
Purchase
2023-11-1713DMolecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P8,696,205
23.900%
2,203,688increase
(+33.94%)
Filing
History
2023-11-17
4:52 pm
Purchase
2023-11-1513DRepare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P10,333,600
24.500%
1,235,000increase
(+13.57%)
Filing
History
2023-11-13
4:45 pm
Purchase
2023-10-3113GenGene Holdings Inc. Common Stock
ENGN
BIOTECHNOLOGY VALUE FUND L P3,196,439
13.200%
3,196,439increase
(New Position)
Filing
History
2023-11-07
4:41 pm
Purchase
2023-11-0313GMolecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P6,492,517
17.900%
1,982,445increase
(+43.96%)
Filing
History
2023-11-06
1:47 pm
Purchase
2023-11-0213DPOINT Biopharma Global Inc.
PNT
BIOTECHNOLOGY VALUE FUND L P17,437,375
16.500%
8,259,627increase
(+90.00%)
Filing
History
2023-11-03
5:20 pm
Purchase
2023-11-0213DRepare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P9,098,600
21.600%
806,612increase
(+9.73%)
Filing
History
2023-10-16
4:34 pm
Purchase
2023-10-0413GVistaGen Therapeutics, Inc.
VTGN
BIOTECHNOLOGY VALUE FUND L P2,777,245
9.990%
2,777,245increase
(New Position)
Filing
History
2023-09-25
4:35 pm
Purchase
2023-08-3113DInventiva S.A.
IVA
BIOTECHNOLOGY VALUE FUND L P8,545,499
16.500%
587,361increase
(+7.38%)
Filing
History
2023-09-18
4:35 pm
Purchase
2023-09-0713GMirum Pharmaceuticals, Inc.
MIRM
BIOTECHNOLOGY VALUE FUND L P4,370,024
9.400%
4,370,024increase
(New Position)
Filing
History
2023-09-14
4:23 pm
Purchase
2023-09-1213DOlema Pharmaceuticals, Inc.
OLMA
BIOTECHNOLOGY VALUE FUND L P9,135,893
16.700%
1,724,390increase
(+23.27%)
Filing
History
2023-08-17
4:52 pm
Unchanged
2023-08-1013DRain Enhancement Technologies Holdco Inc
RAIN
BIOTECHNOLOGY VALUE FUND L P3,526,729
12.800%
0
(Unchanged)
Filing
History
Goto Prev, 0, 1, ...4, 5, 6, 7, 8, ...17, 18, Next